comprehensive -WSS

comprehensive

author：explore 2025-10-01 18:22:44 - browse：19367

Illustration fo a pink arrow pointing downward. -- biotech coverage from STAT — Adobe

SAN DIEGO — Ventyx Biosciences reported on Monday that it was ending development of an experimental drug for treating plaque psoriasis though it proved safe and moderately effective in a mid-stage trial. Within hours, the company’s stock tanked by more than 80%.

That’s because the company announced that the small molecule, VTX958, had not met the biotech’s internal goals to advance to the next phase of clinical development. Ventyx said it would end work on the drug, which targets the signaling molecule TYK2, as a treatment for psoriasis and psoriatic arthritis.

Shares in Ventyx plummeted from $14.09 at market close to as little as $2.72 during after-hours trading. In the process, the company’s market value dropped from $830 million to around $160 million. Ventyx is now trading below its cash balance, which was $300 million as of the end of September.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： After sickle

hotspot

WSS

Eating disorder hotline's move to chatbot carried cost for volunteers

Chemotherapy shortages won’t get better under Biden’s latest plan

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Leukemia patients are helped by Syndax's new type of therapy

Why sickle cell disease is getting the first CRISPR treatment

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

focus

comprehensive

focus

As demand for Covid shots wanes, Moderna seeks its next success

Brazil's Jair Bolsonaro is barred from running for office until 2030

Heart attack and stroke risk calculators need revising

Pregnancy discrimination could be enabled by AI

Peter Hotez and the public health issue of online harassment

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Dobbs anniversary: the lost opportunity of abortion as health care

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Guidelines to prevent youth baseball injuries need more muscle

CMS should re

explore

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Congenital heart disease patients face new threat of heart failure

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

STAT letters to the editor on burnt

Pfizer plans to depart BIO

ADA: All diabetes patients should be screened for liver condition

hotspot

hotspot

leisure time

Wikipedia